NIREZ Trademark

Trademark Overview


On Friday, July 24, 2015, a trademark application was filed for NIREZ with the United States Patent and Trademark Office. The USPTO has given the NIREZ trademark a serial number of 86703911. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 10, 2023. This trademark is owned by Glaxo Group Limited. The NIREZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
nirez

General Information


Serial Number86703911
Word MarkNIREZ
Filing DateFriday, July 24, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 10, 2023
Registration Number5025269
Registration DateTuesday, August 23, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, March 10, 2023CANCELLED SEC. 8 (6-YR)
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 23, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 23, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, June 7, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2016PUBLISHED FOR OPPOSITION
Wednesday, May 18, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 29, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 28, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 27, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 27, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, October 31, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, October 31, 2015NON-FINAL ACTION E-MAILED
Saturday, October 31, 2015NON-FINAL ACTION WRITTEN
Wednesday, October 28, 2015ASSIGNED TO EXAMINER
Thursday, July 30, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 28, 2015NEW APPLICATION ENTERED